Saner Manish V, Kulkarni Abhijeet D, Pardeshi Chandrakantsing V
Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, North Maharshtra University , Maharashtra , India.
J Drug Target. 2014 Nov;22(9):769-89. doi: 10.3109/1061186X.2014.929138. Epub 2014 Jun 25.
Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves patient compliance and reduces treatment cost. However, the success of topical therapy has been hindered due to poor penetration of topical therapeutics across densely keratinized nail plate barrier. For effective topical therapy across nail plate, ungual drug permeation must be enhanced. Present review is designed to provide an insight into prime aspects of transungual drug delivery viz. nail structure and physiology, various onychopathies, techniques of nail permeation enhancement and in vitro models for trans-nail drug permeation studies. Updated list of drug molecules studied across the nail plate and key commercial products have been furnished with sufficient depth. Patents pertinent to, and current clinical status of transungual drug delivery have also been comprehensively reviewed. This is the first systematic critique encompassing the detailed aspects of transungual drug delivery. In our opinion, transungual drug delivery is a promising avenue for researchers to develop novel formulations, augmenting pharmaceutical industries to commercialize the products for nail disorders.
局部治疗因其局部作用,在治疗指甲疾病(尤其是甲癣和指甲银屑病)方面处于前沿地位,它可避免全身不良反应,提高患者依从性并降低治疗成本。然而,由于局部治疗药物难以穿透高度角化的指甲板屏障,局部治疗的效果受到了阻碍。为实现有效的指甲板局部治疗,必须增强药物经指甲的渗透。本综述旨在深入探讨经指甲给药的主要方面,即指甲的结构与生理、各种指甲疾病、增强指甲渗透的技术以及用于经指甲药物渗透研究的体外模型。已详细列出了经指甲板研究的药物分子更新列表以及关键商业产品。还全面综述了与经指甲给药相关的专利及其当前临床状况。这是首次对经指甲给药的详细方面进行系统评论。我们认为,经指甲给药是研究人员开发新型制剂的一条有前景的途径,有助于制药行业将指甲疾病产品商业化。